Novel prognostic and predictive biomarkers (tumor markers) for human breast cancer

摘要

The present invention relates to novel biomarkers for predicting response or resistance to specific therapies (overall survival, OS) and for predicting the prognosis (relapse or progression) of the tumor in a breast cancer patient (disease free survival, DFS). The breast cancer can be chemotherapy-resistant breast cancer, or a relapsing or progressing breast cancer. Further aspects relate to diagnostic kits comprising said biomarkers, and uses thereof.